Tag results:

chronic kidney disease

SIRT6 Protects Vascular Smooth Muscle Cell from Osteogenic Transdifferentiation via Runx2 in Chronic Kidney Disease

[Journal of Clinical Investigation] SIRT6-transgenic mice showed alleviated vascular calcification (VC), while vascular smooth muscle cells-specific, SIRT6 knocked down mice showed severe VC, in chronic kidney disease.

The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease

[American Journal of Nephrology] Investigators summarize the roles of the kynurenine pathway and its metabolites in acute kidney injury and chronic kidney disease based on current literature evidence.

Uremic Serum Damages Endothelium by Provoking Excessive Neutrophil Extracellular Trap Formation

[Scientific Reports] Investigators reported a role for excessive neutrophil extracellular trap formation induced by uremic serum on endothelial cell injury.

RCAN1.4 Attenuates Renal Fibrosis through Inhibiting Calcineurin-Mediated Nuclear Translocation of NFAT2

[Cell Death Discovery] The authors indicated that RCAN1.4 expression was impaired both in unilateral ureteral obstruction-induced renal fibrosis in vivo and TGF-β1-induced renal fibrosis in vitro. However, knocking in of RCAN1.4 suppressed the production of ECM both in vivo and in vitro.

Comparing the Renoprotective Effects of BM-MSCs versus BM-MSC-Exosomes, When Combined with an Anti-Fibrotic Drug, in Hypertensive Mice

[Biomedicine & Pharmacotherapy] Scientists determined whether serelaxin (RLX) could enhance the therapeutic efficacy of bone-marrow-derived- mesecnymal stem cell-exosomes (BM-MSC-EXO), and compared the renoprotective effects of RLX and BM-MSC-EXO versus RLX and BM-MSCs in mice with hypertensive CKD.

Increased β-Adrenergic Stimulation Augments Vascular Smooth Muscle Cell Calcification via PKA/CREB Signalling

[Pflugers Archiv-European Journal of Physiology] Scientists explored the effects of β2-adrenergic stimulation by isoproterenol on vascular smooth muscle cells (VSMC) calcification. Experiments were performed in primary human aortic VSMCs treated with isoproterenol during control or high phosphate conditions.

Popular